AIDS Alert Archives – May 1, 2005
May 1, 2005
View Issues
-
Growing number of drug resistant strains dominates at retroviruses conference
While some researchers, AIDS advocates, and public health officials still debate the wisdom of publicizing the recent New York City case of multidrug resistant HIV that progressed rapidly to AIDS, the one thing everyone can agree upon is that multidrug resistance in newly diagnosed patients is a major problem. -
Drug resistant HIV lingers in female genital tract
Researchers have learned that multiple-resistant HIV is prevalent in genital tracts of women with long antiretroviral therapy histories, and resistant virus can persist even years after the therapy associated with the resistance has stopped. -
Even after diagnosis, risky behaviors persist
An HIV diagnosis lowers risky sexual behavior, but not by as much as public health officials might hope, new research suggests. -
Study examines impact of abuse on HIV patients
New research about HIV patients finds emotional abuse as a child is one of the strongest predictors of poor adherence, alcoholism, and drug abuse. -
Adherence Strategies: Improve bedside manner, affect patient adherence
As clinicians, researchers, and public health officials become increasingly concerned about the development of multidrug resistant HIV, its clear that more research and interventions need to be designed to improve adherence to antiretroviral treatment regimens. -
ADAP recipients offered free HCV drug therapy
In a year that has seen waiting lists grow and funding fall short of increasing needs, the AIDS Drug Assistance Program (ADAP) has received one piece of good news: Up to 1,500 ADAP clients are eligible to enroll for free hepatitis C drug therapy during the next year. -
AIDS Alert International: Global Fund seeks improvements as costs to fight AIDS, TB, and malaria exceed funding commitment
Less than half way into 2005, the Global Fund to Fight AIDS, Tuberculosis and Malaria is short by $950 million of the $2.3 billion needed to renew current grants and make new grants, according to Global Fund data. -
AIDS Alert International: HIV treatment continues to progress in Mexico
In this interview with AIDS Alert, Jorge A. Saavedra, MD, director general of the National Center for Prevention and Control of HIV/AIDS (CENSIDA), Ministry of Health in Mexico, discusses his nations HIV epidemic and response.